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ABSTRACT
￿
Colchicine induces the clustering of at least three different T-lymphoma surface antigens
(T200, Thy-1, and gp 69/71) into a cap structure in the absence of any external ligand . In addition,
colchicine induces the intracellular accumulation of actin and myosin directly beneath the surface
cap structure . We have discovered that myosin molecules (both heavy and light chains) are closely
associated with the plasma membrane of T-lymphoma cells. Most importantly, we have found that
the 20,000-dalton light chain of lymphocyte myosin is both phosphorylated and preferentially
accumulated in the plasma membrane of colchicine-induced capped cells . It is proposed that myosin
light chain is directly involved in the activation of membrane-associated actomyosin required for the
collection of surface proteins into a cap structure (analogous to muscle cell sliding filament contrac-
tion) .
Redistribution of lymphocyte surface receptors can be induced
either with or without the addition of external ligands (15, 18,
23, 29, 30, 37, 41, 46-48) . During the process of receptor
movement, surface components first form small clusters
(patches), which then aggregate at one pole of the cell into so-
called caps .
In the case of ligand-dependent capping, the ligand and its
receptors appear to be clustered by a cross-linking event at the
cell surface that is highly dependent on the valency of the
ligand (37). For example, divalent antibodies against surface
immunoglobulin (Ig) are required for the induction of Ig
capping; monovalent anti-Ig is unable to cause any redistri-
bution of the Ig receptor (30) . In addition, capping induced by
the lectin, concanavalin A (Con A), requires the tetrameric
form ofCon A (at the proper concentration) since the dimer
form (e.g ., succinyl Con A) is not active in cap formation (15,
18) . Information concerning ligand-independent capping is
very limited . Recently, it has been found that hypertonic media,
mitogens, trypsin, and cholinergic drugs are each able to induce
surface receptors to form cap structures in the absence of any
externally added ligand (29, 46-48). The molecular mecha-
nisms underlying both ligand-dependent and ligand-independ-
ent capping are not yet understood .
Previously, we have used a double immunofluorescence
labeling technique to simultaneously determine the distribution
of certain surface receptors and intracellular actin and myosin
inhuman skin fibroblasts grown in monolayers (9) or in murine
lymphoid cells grown in suspension cultures (7, 10, 11) . The
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results of these studies indicate that increased concentrations
of actin and myosin are always found directly under the capped
membrane (7, 9-11) . Consequently, we have proposed that a
"transmembrane interaction" (10) occurs between the surface
receptors and intracellular actin- and myosin-containing struc-
tures that allows the receptors to be actively collected into a
cap by a mechanism analogous to the muscle sliding filament
contraction process. However, conclusive biochemical evidence
for or against these proposed interactions between contractile
elements and surface membrane proteins has not been obtained
as yet.
In this study, we have focused on the phenomenon ofligand-
independent capping in mouse T-lymphoma cells, using both
immunocytochemical and immunobiochemical techniques to
explore the possible molecular mechanisms involved in the
redistribution process . We have established that colchicine
induces all three surface proteins tested to form caplike struc-
tures in the absence of any external ligand . As with ligand-
dependent capping, colchicine-induced capping is sensitive to
both temperature and cytochalasin D and is accompanied by
the accumulation of intracellular actin and myosin under the
surface cap structure.
Most importantly, we have found that during colchicine-
induced capping the 20,000-dalton light chain of lymphocyte
myosin is preferentially accumulated in plasma membrane of
T-lymphoma cells and is alsophosphorylated. These alterations
in myosin light chain phosphorylation suggest that activation
of membrane-associated actomyosin (possibly analogous to
889that occurring in muscle sliding filament contraction) is re-
quired for the collection of surface receptors into a cap struc-
ture.
MATERIALS AND METHODS
The mouse T-lymphoma cell line, AKR/J lymphoma line BW 5147 (gift from
Dr . R. Hyman, The Salk Institute)grown in Dulbecco's modified Eagle's medium
supplementedwith 10% heat-inactivated horse serum(Gibco Laboratories, Grand
Island, N.Y.) at 37°C in 5% COz/95% air . TheseT-lymphoma cells display the
surface antigens T200, Thy-1, and gp 69/71 (8).
Monoclonal rat antisera against T200 (39), Thy-1, and gp 69/71 were gener-
ously provided byDr . I. Trowbridge, The Salk Institute . The individual antiserum
each precipitates a single polypeptide corresponding to T200, Thy-1, or gp 69/71
molecules from detergent extracts ofBW 5147 cells surface-labeled by lactoper-
oxidase-catalyzed iodination (8) .
Unfixed cells (-I x 10' cells/ml) were treated with 0.1 mM colchicine (Sigma
Chemical Co ., St . Louis, Mo .) at either 0°C for 1 h or 37 °C for 15 min.
Colchicine-treated cells were fixed with 2% paraformaldehyde at 0°Cand labeled
with rat antisera against surface molecules (e.g., T200, Thy-1, and gp 69/71)
followed by rabbit anti-rat immunoglobulin and rhodamine- or fluorescein-
conjugated goat antibody against rabbit immunoglobulin at 0°C .
Cell suspensions (I x 10' cells/ml) were incubated with 0.1 mM colchicine
plus 20 ug/ml cytochalasin D (Sigma Chemical Co .) for 15 min at either 0° or
37°C . Drug-treated cells were then treated with antibodies to label surface
molecules as described above .
For simultaneous localization ofsurface proteins and intracellular actin, after
colchicine treatment, cells were fixed with 2% paraformaldehyde at 0°C. Surface
proteinssuch as T200 were labeledwith rhodamine-conjugated antibody reagents
as mentioned above . Subsequently, these rhodamine-labeled cells (Rh-T200)
were rendered permeable by either acetone extraction or frozen-thick-sectioning
procedures (I1) and stained with 200 wg/ml fluorescein-conjugated heavy mero-
myosin (Fl-HMM) (a gift fromW . A. Turner, Jr., Wayne State University) at
0°C fordetection ofcytoplasmic actin. As acontrol, somesampleswere incubated
in a solution of 10 mM pyrophosphate plus 2 mM MgC12 in the presence of FI-
HMM at 0°C . No actin labeling was detected in these control samples. Similar
double immunofluorescence procedures were also carried out between other
surface proteins (e.g ., Thy-l and gp 69/7 l) and actin .
For simultaneous localization of intracellular actin and myosin molecules,
cells (either with or without colchicine treatment) were first fixed with 2%
paraformaldehyde at 0°C and rendered permeable by frozen sectioning (11) and
stained with Fl-HMM as described above for the localization of intracellular
actin . To detect the presence of intracellular myosin, rabbit antibodies to human
uterus smooth muscle myosin (32) were applied followed by rhodamine-labeled
goat antibodies against rabbit immunoglobulin. As controls, normal rabbit im-
munoglobulin or preimmune rabbit immunoglobulin was used instead of the
rabbit antimyosin antibodies . No myosin staining was detected in the control
samples.
These fluorescein- and rhodamine-labeled samples were examined under a
Zeiss photomicroscope using a 40 x oil-immersion lens with epi-illumination and
filter system of CZ 487710 andCZ 487714, respectively . Cells were photographed
on Kodak Plus-X film.
Purified myosin (from human uterus smooth muscle) (32) wasadded (10mg/
ml) to glutaraldehyde-activated Ultrogel (ACA 22 ;LKB Instruments, Inc., Rock-
ville, Md .) (14) at 4°C for 6 h to prepare myosin-conjugated gel beads . Antisera
against human uterus smooth muscle myosin (IgG fraction) was then passed
through a small column of myosin-conjugated Ultrogel, and the eluent not
binding to the myosin-column was used as the antimyosin-free or preabsorbed
reagent in control experiments related to the immunoprecipitation studies .
Plasma membrane was isolated by the method described by Johnson and
Bourne (20) with modification . Cells were harvested by low-speed centrifugation
(500 g,), washed twice with Dulbecco's phosphate-buffered medium and resus-
pended at a density of 10' cells/ml in 20 mM HEPES, 2 mM MgC12, l MM
EDTA, I mM 2-mercaptoethanol, pH 7.4, at 4°C . Cells were disrupted with a
Dounce homogenizer . The lysate was centrifuged at 750g_ for 5 min and the
supernatant was centrifuged in an SW50 .1 rotor (Beckman Instruments, Inc .,
Palo Alto, Calif) at 43,000 g ,R for 20 min. The pellet was resuspended in 10%
sucrose (wt/wt), 20 mM Na-HEPES, 2 mM MgC1z , I mM EDTA, 1 mM 2-
mercaptoethanol, pH 8.0, and layered over a discontinuous gradient of 20, 30, 40,
and 50% sucrose (wt/wt) in the same buffer and centrifuged in a Beckman SW
50 .1 rotor at 100,000 ga,  for 80 min . The membrane between 30 and 40% was
collected, and washed with Dulbecco's phosphate-buffered saline. Surface
markers such as T200, Thy-1, and gp 69/71 are noted to be preferentially
collected in this particular plasma membrane fraction by lactoperoxidase-cata-
lyzed iodination and immunoprecipitation techniques (8, 39, 40) . Cells (I x 10'
cells/ml) were washed with phosphate-free Dulbecco's modified Eagle's medium
890
￿
RAPID COMMUNICATIONS
and then incubated in the same medium either with or without 0.1 mM colchicine
for 5 min at 37 °C. Subsequently, 0.2 mCi "P (H,'"P0,, carrier free ; ICN
Pharmaceuticals, Irvine, Calif) was added to both cell suspensions at room
temperature or 37 °C for 10 min. Phosphorylation was terminated by adding an
excess amount (10 vol) of unlabeled 0.1 M phosphate-buffered saline at 0°C .
Phosphorylated cells (with or without colchicine treatment) were processed
for plasma membrane isolation procedure as described above . The radioactive
membranes were solubilized with 0.1% Nonidet P-40 (NP-40) in 10 mM Tris-
HC1, pH 8.0, at 4°C for 30 min . The solubilized membrane fractions were then
incubatedwith either rabbit antimyosin or antimyosin-free (preabsorbed)antisera
at 4°C for 30 min. Subsequently, goat anti-rabbit immunoglobulin wasadded to
the samples at 4°C for 30 min to induce immunoprecipitation (40) . The immu-
noprecipitates were obtained by centrifugation at 12,000 gR for 10 min; each
precipitate was washed using the same centrifugation method with phosphate-
buffered saline three times . The polypeptide composition and radioactivity
analysis of the immunoprecipitates were carried out according to the procedures
described below . Similar immunoprecipitation procedures were also carried out
using NP-40-solubilized whole-cell homogenate of mouse T-lymphoma cells and
purified iodinated smooth muscle myosin preparation .
Electrophoresis was carried outon slab gels using an exponential polyacryl-
amide gel gradient (7.0-17.5%) and the discontinuous buffer system described by
Laemmli (21) . All samples were dissolved in a buffer containing 2% SDS, 0.1 M
dithiothreitol, 0.002% bromophenol blue, 20 mM Tris-HCI, pH 8.9, and heated
at 100° for 2min. Approximately 125 wg ofprotein per sample (e .g ., total plasma
membrane or immunoprecipitates) was applied to the gel . Electrophoresis was
run at a constant current of 2 mA for 18 h at room temperature, and the
polypeptide banding pattern was revealed by staining with Coomassie Blue . In
the case of samples labeled with "P, the gels were dried and exposed to Kodak
x-ray (X-Omat, XR-1) film . In some cases, the bands corresponding to certain
polypeptides (e .g ., myosin heavy chain and light chain) were cut out of the gel
and the level ofradioactivity determined using Aquasol(New England Nuclear,
Boston, Mass .) and a liquid scintillation counter. For "'I-labled samples, the gels
were cut into 1.5-mm slices . The radioactivity of these gel slices was determined
using Beckman Gamma Spectrometer.
RESULTS
We have explored the effect of colchicine on the distribution
of lymphocyte receptors in the absence of added ligand . As
shown in Fig . 1 a, c, and d, we have found that colchicine alone
(i .e ., without any ligand) induces a number of lymphocyte
surface molecules (e.g ., T200, Thy-1, and gp 69/71) to form
typical cap structures . In addition, this colchicine-induced cap-
ping is dependent on temperature and sensitive to cytochalasin
D (Fig . 1b and Table I), as is ligand-induced capping .
We have also utilized the double immunofluorescence label-
ing technique to simultaneously localize intracellular actin,
myosin, and surface receptor molecules on the same cells after
colchicine treatment . Our data show that there is a large
accumulation of actin molecules at the pole of the cells where
surface proteins such as T200, Thy-1, or gp 69/71 are collected
into cap structures (Fig . 2a and b) . In addition, myosin is
aggregated in the same region as actin under the capped
structures of the cells after treatment with colchicine (Fig . 2 c,
d, e, andf) .
In this study, the total plasma membrane isolated from
untreated cells was compared with that obtained from cells
treated with colchicine . In both cases, the plasma membrane
was purified at least 20-fold (26) and shown by electron micro-
scope examination to contain essentially no other membra-
neous contaminants (e.g., no rough endoplasmic reticulum and
no detectable nuclear or mitochondrial membranes [data not
shown]) . Using exponential acrylamide gradient gel electro-
phoresis to display the membrane polypeptides, we have found
that there are at least 30 major polypeptides present in both
plasma membrane preparations and there are no obvious dif-
ferences between the two gel banding patterns (Fig . 3A and
B) . This latter result is not surprising since capping primarily
involves a local rearrangement of surface receptor molecules .
We have noted from the gel patterns that a band travelingFIGURE 1
￿
Effect of colchicine on lymphocyte capping . (a) Cells were treated with colchicine (1 X 10-° M) for 15 min, fixed with
2% paraformaldehyde, and labeled with monoclonal rat anti-T200 followed by rabbit anti-rat IgG and Fl-goat anti-rabbit IgG . (b)
Cells were treated with colchicine (1 x 10-° M) and cytochalasin D (20 pg/ml) for 15 min, fixed, and labeled the same way as
described in a forT200 protein . (c) Cells were treated with colchicine (1 X 10-° M), fixed with 2% paraformaldehyde, and stained
with monoclonal rat anti-Thy-1 followed by rabbit anti-rat IgG and Fl-goat anti-rabbit IgG . (d) Cells were treated with colchicine
(1 x 10-° M), fixed with 2% paraformaldehyde, and stained with monoclonal rat anti-gp 69/71 followed by rabbit anti-rat IgG and
Fl-goat anti-rabbit IgG. x 1,300 .
TABLE I
￿
with the same electophoretic mobility as actin appears to be
Effect of Temperature and Various Drugs on Surface Capping
￿
present in equal amounts in the plasma membrane fraction
from both capped and uncapped cells (Fig. 3A and B). With
/° myosin, however, we were not able to determine whether there
were any differences on the two SDS polyacrylamide gels
because myosin is present in very low amounts in the plasma
membrane fraction and comigration ofrelatively largeamounts
omemrane poypepteswthmolecuarwegtsclose to thf
￿
blidili
cytochalasin D (20pg/ml)
￿
at
of myosin could easily obscure both quantitative and qualita-
* The data are essentially identical for T200, Thy-1, and gp 69/71 capping .
￿
tiva differences .
Standard deviation is ± 5% .
FIGURE 2
￿
Simultaneous localization of actin, myosin, and surface T200 proteins. Cells were either treated with colchicine (1 X
10-" M) for 15 min (a, b, d-f), or untreated (c) . All cells were fixed with 2% paraformaldehyde and stained for surface T200 (or
Thy-1, gp 69/71) using monoclonal rat anti-T200 (or Thy-1, gp 69/71) followed by rabbit anti-rat IgG and rhodamine-goat anti-
rabbit IgG. Surface labeled cells were extracted with acetone and labeled with Fl-HMM for detection of actin . Other cells were
frozen-sectioned and labeled for intracellular actin and myosin . (a) Colchicine-treated cells ; actin labeling . ( b) Colchicine-treated
cells ; surface T200 labeling . (c) Untreated cells ; myosin labeling . (d) Colchicine-treated cells ; myosin labeling . (e) Colchicine-
treated cells ; actin labeling . (f) Colchicine-treated cells ; myosin labeling . Arrowheads indicate that location of caplike structures .
x 1,300.
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Conditions Drug Capping*
0°C, 60 min Colchicine (1 x 10-° M) 1
37°C, 15 min Colchicine (1 X 10-° M) 40
37°C, 15 min Colchicine (1 X 10-° M) + 1FIGURE 3 SDS polyacrylamide gel analysis of the plasma mem-
branes and myosin-specific immunoprecipitate polypeptides . (A)
Plasma membranes from untreated cells . (8) Plasma membrane
from colchicine-treated capped cells (arrowhead indicates actin
bands) . (C) Antimyosin immunoprecipitate from plasma membrane
fraction of untreated cells . (D) Antimyosin immunoprecipitate from
plasma membrane fraction of colchicine-treated capped cells . (E) A
typical gel pattern of following sample: (1) Antimyosin-free (preab-
sorbed reagent)/(nonspecific) immunoprecipitates from whole-cell
homogenate of mouse T-lymphoma as well as plasma membrane
fractions of colchicine-treated or untreated cells ; (2) antimyosin
immunoprecipitates from human skeletal muscle tropomyosin . (F)
Human skeletal muscle tropomyosin . (G) Antimyosin immunopre-
cipitates of whole-cell homogenate of untreated T-lymphoma cells .
(H) Antimyosin immunoprecipitates of purified human smooth
muscle myosin protein . (Markers used in the study are [in
daltons] : myosin, 200,000 ; fl-galactosidase, 130,000 ; lactoperoxidase,
78,000; bovine serum albumin, 68,000; actin, 40,000; concanavalin A,
25,000; soybean trypsin inhibitor, 17,000 ; cytochrome c, 12,000 .
Consequently, the technique of immunoprecipitation was
employed to further study the myosin found in the capped and
uncapped cells . The myosin antibodies (rabbit antibodies
against human uterus smooth myosin) used throughout these
studies were shown to specifically immunoprecipitate only the
myosin heavy chain at 200,000 daltons (MH200K) and one of
the myosin chains at 20,000 daltons (MLC20K) from smooth
muscle systems (Fig. 3H and Fig . 4) (32) . Our antimyosin
reagent has also been found by immunofluorescence techniques
to exhibit a very wide range of cross-reactivity with myosin
molecules from a number of different types of animal cells (7,
We have carried out immunoprecipitation using the anti-
myosin antiserum on the whole-cell homogenate fraction from
mouseT-lymphoma cells . The proteins in the precipitates were
then analyzed by SDS PAGE . Our results show that, in addi-
tion to the two typical myosin chains (MH2WK and MLC20K),
there is an additional polypeptide (28,000 daltons [28K]) pres-
ent in the immunoprecipitates from both colchicine-treated
and untreated cells (Fig . 3 G). The presence ofthe 28K protein
could be attributed to either a cross-reactivity of the 28K
protein with myosin antibody or to a physical association
between the 28K and myosin proteins that exists in vivo . We
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consider the antimyosin-mediated precipitation to be specific
for the following reasons : (a) after the removal of antimyosin,
no myosin or little 28K protein can be detected in the nonspe-
cific immunoprecipitates (Fig . 3E) ; and (b) this reagent does
not cross-react with other contractile proteins such as tropo-
myosin and actin (Fig. 3 E, F, and G) .
Starting with equal amounts of capped and uncapped cells,
we have found that there is relatively little myosin light chain
present in the plasma membrane fraction of untreated (un-
capped) cells (Fig. 3C). However, MLC20K is readily detected
in the immunoprecipitates of the plasma membrane prepara-
tion from capped (i .e ., colchicine-treated) cells (Fig. 3 D) .
Therefore, during colchicine-induced lymphocyte capping,
there appears to be an additional, specific association of
MLC20K with the plasma membrane.
Since several studies have suggested that phosphorylation of
myosin light chain may be crucial for the overall regulation of
contractility in both muscle and nonmuscle cells (1, 2, 12, 13,
16, 31, 33, 49), we decided to determine whether myosin phos-
phorylation also occurs during colchicine-induced capping.
Initially, we metabolically labeled uncapped cells with carrier-
free HPP04 in phosphate-free Dulbecco's modified Eagle's
FIGURE 4
￿
Immunoprecipitation of human smooth muscle myosin .
Human smooth muscle myosin was isolated (32), iodinated (17, 19),
and processed through immunoprecipitation reactions using either
antimyosin antibody (") or antimyosin-free (preabsorbed) antibody
(0) reagent according to the procedures described in the text .
Immunoprecipitates were analyzed on an exponential polyacryl-
amide gel gradient (7.0-17.5%) and the discontinuous buffer system
described by Laemmli (21) . The gels were stained with Coomassie
Brilliant Blue, sliced, and counted for their radioactivity (myosin ,
myosin heavy chain ; myosin L , myosin light chain ; IgG , immuno-
globulin heavy chain; and IgGL, immunoglobulin light chain) . Mo-
lecular weight markers used in this experiment are identical to those
used in Fig . 3 .
TABLE II
Protein Phosphorylation
Conditions
32p/
MH200K
32P/
MLC2olt
32P/28K
protein
cpm/ mg cpm/ mg cpm/ mg
Untreated cells ND* 2.23 x 10 5 3 .0 x 105
Colchicine-treated cells ND* 1.92 x 106 1 .5 x 106
* ND, not detectable .medium and determined that both the MLC2ox and the 28K
proteins are phosphorylated but the MH2o0K is not phosphor-
ylated at all (Table II) . We then examined myosin and 28K
protein from cells induced to form caps by treatment with
colchicine and found a very marked increase (at least five- to
eightfold) in the phosphorylation of bothMLC2ox and the 28K
protein as early as 5 min after incubation of cells with this
drug . Again, there was no detectable phosphorylation of
MH2o0K (Table II) . As a control, we have determined the total
amount of radioactive phosphate incorporation into both total
cellular proteins and the plasma membrane fraction . Since the
incorporation is exactly the same for both untreated and col-
chicine-treated cells (data not shown), there appears to be no
significant difference in the uptake of phosphateby colchicine-
treated and untreated cells .
DISCUSSION
Generally, it has been thought that capping requires the bind-
ingofa multivalent ligand in order to cross-link the membrane
receptors . In this study, we have shown that the antimitotic
drug, colchicine, is able to induce the capping of at least three
specific mouse T-lymphoma surface receptors (T200, Thy-1,
and gp 69/71) in the absence of any external ligand (Fig . 1) .
Although colchicine has been known to stimulate ligand-de-
pendentcapping (e.g ., withConA) (45), the abilityofthis drug
to induce ligand-independent capping in lymphocytes has not
been previously reported. Recently, Walter et al . (42) have
shown that colchicine is able to induce macrophages to accu-
mulate phagocytic and pinocytic vesicles as well as Con A
receptors into a cap structure at one pole ofthe cell .
The primary mode of action of colchicine has been com-
monly considered to involve the disassembly of microtubules
(4, 5, 22, 27, 44) . However, colchicine has also been found to
affect several other cellular activities (e.g., nucleoside transport
and membrane components) (25, 34, 35) . We have obtained
preliminary data using lumicolchicine, an analogue of colchi-
cine known to have no effect on microtubule structure, which
indicates that it also can induce lymphocyte capping (Bour-
guignon and Hsing, submitted for publication) . Therefore, the
involvement of microtubules in the capping process is still an
open question. However, the participation of actomyosin mol-
ecules in the receptor redistribution of surface receptors is quite
definite as shown by both actin and myosin molecules being
preferentially accumulated directly underneath the colchicine-
treated receptor cap structure (Fig . 2) .
By employing an immunoprecipitation procedure specific
for myosin, we have determined that our antimyosin reagent
exhibits cross-reactivity with both heavychain and light chain
myosin in purified myosin preparations and whole-cell homog-
enates of T-lymphoma cells (Fig. 3G and H, and Fig . 4) . The
fact that the antimyosin reagent can also immunoprecipitate a
28K protein together with myosin raises the following two
interesting possibilities : (a) the 28K protein may be closely
associated with myosin, especially in whole cell and plasma
membrane fractions, but is apparently dissociated from myosin
during purification ; or (b) the 28K protein may contain a
myosinlike structure that is immunologically indistinguishable
from myosin . Of course, it is also possible that the 28Kprotein
may be somehow induced to form an immunoprecipitatecom-
plex with myosin during the immunoreaction. Recently, in an
independent study using a nonimmunological approach, we
obtained evidence indicating that the 28K protein is a phos-
phorylated membrane protein that coexists with the MLC2ox
in the lymphocyte capped structure (6) . Therefore, we believe
that the coexistence of the 28K protein with myosin in the
immunoprecipitates most likely results from a real association
and not an artificially induced complex . The fact that the
protein can be readily phosphorylated and that the extent of
its phosphorylation correlates with the capping process suggests
that the 28Kprotein maytake part either in the linkage process
between plasma membrane and contractile proteins or in the
regulatory events involving the actomyosin machinery during
lymphocyte capping .
Furthermore, we have found that there is significantly more
MLC2ox protein (-20-fold) in the immunoprecipitate obtained
from the plasma membrane of capped cells than in that from
the uncapped cells (Fig. 3C and D) . There are two possible
reasons for this difference-either there is much less MLC2ox
protein attached (directly or indirectly) to plasma membrane
of uncapped cells or the antigenic sites for the myosin antibody
are somehowmasked in the plasma membrane oftheuncapped
cell. At this time, we are not able to confirm either possibility.
However, in either case, it is clear that colchicine-mediated
capping is causing some change related to MLC2ox that is
potentially important for understanding the mechanism of
surface receptor movement .
Another potentially important finding is that colchicine in-
duces a significant increase (approximately eightfold) in the
phosphorylation of the MLC2ox (but not MH2o0K), which may
be required for the activation of actomyosin complex during
receptor capping . The possible relationship between the asso-
ciation of MLC2ox with the plasma membrane and the exten-
sive phosphorylation of MLC2ox upon the treatment wick
colchicine is currently under investigation. We have obtained
preliminary data indicating that similar biochemical changes
in MLC20K occur during ligand-dependent and ligand-inde-
pendent lymphocyte receptor redistribution .
Phosphorylation of myosin light chains has been shown to
take place in a variety of cell types, including skeletal muscle
cells (3, 28, 36), smooth muscle cells (12, 16, 33), and nonmuscle
cells (2, 13, 31, 38, 49) . For instance, the degree of phos-
phorylation of MLC2ox (3, 24, 28, 36) appears to correspond to
the extent of posttetanic potentiation of skeletal muscle . In
smooth muscle cells and a number of nonmuscle cells (e.g .,
human platelets, proliferating myoblasts, BHK-21 cells), phos-
phorylation of light chain myosin hasbeen shown to enhance
the actin-activated Mg-ATPase of myosin molecules (2, 12, 13,
16, 31, 33, 38, 49) . This process may be a central event in the
overall regulation of contractility in both muscle cells and
nonmuscle cells . Consequently, we propose that the observed
colchicine-induced phosphorylation of MLC2ox and, possibly,
of the 28K protein may actually modify the attachment of
myosin to the plasma membrane, which subsequently activates
an actomyosin sliding filament mechanism to collect certain
surface receptors into a cap structure .
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